Scientific work

Uzm. Dr. Meryem Şener

26 publications. The source of the information is stated next to each publication.

Back to profile

  1. Olgular Eşliğinde Erişkin Hematoloji

    Akademisyen Kitabevi eBooks, 2026

    DOI 10.37609/akya.4308 Open-access full textSource: OpenAlex

  2. Long-Term Treatment Outcomes and Prognostic Factors in Patients with Chronic Myeloid Leukemia: A 24-Year Single-Center Retrospective Study

    Medicina, 2026

    DOI 10.3390/medicina62112150 Open-access full textSource: ORCID

  3. Factors Affecting Time to First Treatment in Early-Stage Chronic Lymphocytic Leukemia: A Single-Center Retrospective Cohort Study

    Diagnostics, 2026

    DOI 10.3390/diagnostics16213532 Open-access full textSource: ORCID

  4. Treatment Patterns, Treatment Response, and Survival Outcomes in Patients with Multiple Myeloma: A Single-Center Real-World Study

    Journal of Clinical Medicine, 2026

    DOI 10.3390/jcm15218340 Open-access full textSource: ORCID

  5. Esansiyel Trombositemiden Sekonder Myelofibroza Dönüşüm: Genç Bir Olgu

    Akademisyen Kitabevi eBooks, 2026

    DOI 10.37609/akya.4308.c19912 Source: ORCID

  6. Diagnostic Concordance and Superiority of Flow Cytometry Over Immunohistochemistry in Acute Leukemia Immunophenotyping: A Single-Center Study

    Medical Science Monitor, 2026

    DOI 10.12659/msm.952903 PMID 42563366 Open-access full textSource: OpenAlex

  7. Effects of ferric carboxymaltose on hypophosphatemia in patients with iron deficiency anemia: A single-center retrospective study

    Medicine Science | International Medical Journal, 2026

    DOI 10.5455/medscience.2026.01.09 Open-access full textSource: OpenAlex

  8. TREATMENT MANAGEMENT IN MULTIPLE MYELOMA WITH RENAL DISORDER

    Hematology, Transfusion and Cell Therapy, 2025

    DOI 10.1016/j.htct.2025.103905 1 citation (OpenAlex) Open-access full textSource: ORCID

  9. EZH-2 expression and prognostic significance in patients with low-grade non-Hodgkin lymphoma

    Scientific Reports, 2025

    DOI 10.1038/s41598-025-04394-6 PMID 40456891 Open-access full textSource: ORCID

  10. Immune and Inflammation Markers as a Predictor of Overall Survival in Patients with Hematologic Malignancies: A Retrospective Cohort Study

    Medicina, 2025

    DOI 10.3390/medicina61061019 PMID 40572707 17 citations (OpenAlex) Open-access full textSource: OpenAlex

  11. Current view on the etiopathogenesis of aplastic anemia

    Korean Journal of Physiology and Pharmacology, 2025

    DOI 10.4196/kjpp.24.214 PMID 40288994 2 citations (OpenAlex) Open-access full textSource: OpenAlex

  12. POSTER: CLL-340 Prognostic Significance of Neutrophil and Monocyte Counts in Chronic Lymphocytic Leukemia (CLL)

    Clinical Lymphoma Myeloma & Leukemia, 2025

    DOI 10.1016/s2152-2650(25)00668-8 Source: OpenAlex

  13. CLL-340: Prognostic Significance of Neutrophil and Monocyte Counts in Chronic Lymphocytic Leukemia (CLL)

    Clinical Lymphoma Myeloma & Leukemia, 2025

    DOI 10.1016/s2152-2650(25)01846-4 Source: OpenAlex

  14. A retrospective cross-sectional study to investigate femoral head avascular necrosis in sickle cell disease in Türkiye

    Blood, 2025

    DOI 10.1182/blood-2025-1162 Open-access full textSource: OpenAlex

  15. CHRONİC LYMPHOCYTIC LEUKEMIA (CLL): IMMUNOGENETICS AND DIAGNOSIS

    Hematology Transfusion and Cell Therapy, 2025

    DOI 10.1016/j.htct.2025.106209 Open-access full textSource: OpenAlex

  16. CLINICAL CHARACTERISTICS AND TREATMENT OUTCOMES IN ADULT ITP PATIENTS: A SINGLE-CENTER EXPERIENCE

    Hematology Transfusion and Cell Therapy, 2025

    DOI 10.1016/j.htct.2025.106129 Open-access full textSource: OpenAlex

  17. A Case of Multiple Myeloma with Atypical Cutaneous Presentation Treated by Daratumumab + CYBORG

    Hematology, Transfusion and Cell Therapy, 2024

    DOI 10.1016/j.htct.2024.04.017 Open-access full textSource: ORCID

  18. A Rare Intersection: Case Study on Sickle-Cell Thalassemia and Lymphoma

    Hematology, Transfusion and Cell Therapy, 2024

    DOI 10.1016/j.htct.2024.04.019 1 citation (OpenAlex) Open-access full textSource: ORCID

  19. Essential Thrombocythemia Complicated by Addison's Disease: A Case of Overlapping Endocrine and Hematological Disorders

    Hematology, Transfusion and Cell Therapy, 2024

    DOI 10.1016/j.htct.2024.04.018 Open-access full textSource: ORCID

  20. Allojenik Kemik İliği Nakli İle Tedavi Edilen Langerhans Hücreli Histiyositoz Olgusu

    Akademisyen Kitabevi eBooks, 2024

    DOI 10.37609/akya.2870.c11273 Source: ORCID

  21. Pansitopeni ve Organomegali ile Gelen Hastada Visseral Leishmania Olgusu

    Akademisyen Kitabevi eBooks, 2024

    DOI 10.37609/akya.2870.c11285 Source: ORCID

  22. Vakalarla Hematoloji

    Akademisyen Kitabevi eBooks, 2024

    DOI 10.37609/akya.2870 Open-access full textSource: ORCID

  23. Peripheral T-cell Lymphoma with Jaundice: Insights from a Complex Case

    Hematology Transfusion and Cell Therapy, 2024

    DOI 10.1016/j.htct.2024.04.020 Open-access full textSource: OpenAlex

  24. From Diagnosis to Recovery: Addressing Rare Malaria with Travel History Using Standard and Apheresis Therapies

    Hematology Transfusion and Cell Therapy, 2024

    DOI 10.1016/j.htct.2024.04.047 Open-access full textSource: OpenAlex

  25. Challenging the Presentation Paradigm in DLBCL: A Case Study of Extraordinary Disease Distribution

    Hematology Transfusion and Cell Therapy, 2024

    DOI 10.1016/j.htct.2024.04.046 Open-access full textSource: OpenAlex

  26. EZH2 expression and its prognostic significance in patients with low - grade non-hodgkin lymphoma.

    Çukurova University Institutional Repository, 2019

    Open-access full textSource: OpenAlex